Researchers from The Wistar Institute and ChristianaCare Identify Promising New Therapeutic Target for Pancreatic Cancer

Researchers from The Wistar Institute and ChristianaCare Identify Promising New Therapeutic Target for Pancreatic Cancer
Newswise imageScientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential therapy.